Observational studyFrontiers in endocrinology2026
Preoperative inferior vena cava ultrasound for volume optimization in resection of functioning pheochromocytoma and paraganglioma: association with perioperative adverse outcomes in a prospective observational cohort.
Observational study in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Optimizing intravascular volume (IV) before surgery is crucial for patients undergoing resection of functioning pheochromocytomas and paragangliomas (PPGLs). While point-of-care ultrasound (POCU) is a noninvasive technique to assess IV, the use of POCU to evaluate preoperative IV and its relationship to perioperative adverse outcomes (PAOs) remains largely unexplored. Methods: We conducted a prospective cohort study including patients who underwent PPGL resection following preoperative α-blockade. Preoperative IV was assessed using inferior vena cava (IVC) ultrasound and clinical parameters. We used logistic regression models to examine the associations between preoperative IV and intraoperative hemodynamic instability (IHI), perioperative organ dysfunction (POD), and PAO. We also compared the predicting abilities of IVC ultrasound measurements and clinical parameters for PAOs. Results: A total of 80 patients were recruited and analyzed. The study population carried a heavy comorbidity burden (median age-adjusted Charlson Comorbidity Index 4), thus the median duration of preoperative α-blockade was 60 (30, 98) days. Based on IVC ultrasound, 27 patients were classified as having appropriate volume status and 53 as inappropriate volume status. We found no significant association between IVC ultrasound assessed IV status and IHI, POD, and PAO. Furthermore, neither IVC ultrasound assessments nor clinical parameters could discriminate PAOs, and the predictive performance of the two methods did not differ significantly. However, this finding should be interpreted with caution, as the study was likely to be underpowered (enrolled 80 of 364 planned patients, 22%). Conclusion: In this study with a sample size of 80 patients, no independent association was found between preoperative IVC ultrasound measurements and PAOs in patients undergoing PPGL resection with an extended duration of preoperative α-blockade preparation [60 (30, 98) days]. The utility of point-of-care IVC ultrasound in guiding preoperative volume optimization for these patients merits further exploration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.